# Question 93

## Prompt

In the document JOHNSON JOHNSON 2023 8K dated-2023-08-30, What is the amount of the cash proceeds that JnJ realised from the separation of Kenvue (formerly Consumer Health business segment), as of August 30, 2023?

## Response

```results
[
  {
    "citation": "Filename: JOHNSON_JOHNSON_2023_8K_dated-2023-08-30.pdf, pages: 4-5",
    "reason": "Gestell selected this node for containing the specific amount of cash proceeds from the Kenvue separation, as of August 30, 2023."
  }
]
```

```cot
1. **Document and Section:** Analyze the "JOHNSON JOHNSON 2023 8K dated-2023-08-30" document. Focus on the sections detailing the Kenvue separation and the financial impact of this spin-off.  Specifically, look for sections discussing the financial terms of the separation, including cash proceeds received by Johnson & Johnson.

2. **Analysis and Calculation:**
   * Carefully review the 8-K filing to locate the explicit mention of the cash proceeds Johnson & Johnson received from the Kenvue spin-off.  The document should clearly state the amount.  There are no calculations required; the answer is directly stated within the document.

3. **Response Rules:**
   * Extract the exact amount of cash proceeds from the 8-K filing.
   * Format the amount according to the provided guidelines (billions with 1 decimal place and a zero).
   * Present the final answer as a single bullet point.  No additional commentary is needed as the answer is directly stated in the document.
   * If the document does not provide a specific cash proceeds amount, state that the information is not available.


```

- Johnson & Johnson secured $13.2 billion in cash proceeds from the Kenvue debt offering and initial public offering.

**Final Answer:** $13.2 billion

## Correct Answer

JnJ realised $13.2 billion in cash proceeds from the separation of Kenvue.
